← Back to catalogue

TCL1 (MRQ-7) Mouse Monoclonal Antibody

FDA UDI

Class I (US FDA UDI)

by Cell Marque Corporation

Identity

Trade Name
TCL1 (MRQ-7) Mouse Monoclonal Antibody FDA UDI
Generic Name
T-cell leukaemia/lymphoma protein 1 (TCL1) IVD, antibody FDA UDI
Model / Reference
357M-18 FDA UDI

Identifiers

Primary DI / UDI-DI
00841683138419 FDA UDI
FDA Product Code
NJT FDA UDI
GMDN Term
T-cell leukaemia/lymphoma protein 1 (TCL1) IVD, antibody FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
864.1860 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: T-cell leukaemia/lymphoma protein 1 (TCL1) IVD, antibody

TCL1 (MRQ-7) Mouse Monoclonal Antibody by Cell Marque Corporation — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as T-cell leukaemia/lymphoma protein 1 (TCL1) IVD, antibody.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Cell Marque Corporation

Sources (1)

  • FDA UDI bf2dca71-48c4-42de-b3df-3fcb40e0af8a 33 fields · synced Jun 6, 2026